KeyCorp Cuts Acadia Healthcare (NASDAQ:ACHC) Price Target to $65.00

Acadia Healthcare (NASDAQ:ACHC) had its price objective reduced by KeyCorp from $70.00 to $65.00 in a research report sent to investors on Monday,Benzinga reports. KeyCorp currently has an overweight rating on the stock.

A number of other brokerages also recently weighed in on ACHC. TD Cowen lowered their target price on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $64.00 price target on shares of Acadia Healthcare in a research note on Friday, January 10th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $52.00 price target on shares of Acadia Healthcare in a research note on Tuesday, December 10th. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price target for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare has a consensus rating of “Hold” and a consensus price target of $56.31.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $29.68 on Monday. Acadia Healthcare has a twelve month low of $28.09 and a twelve month high of $85.96. The firm has a fifty day simple moving average of $41.79 and a 200 day simple moving average of $51.01. The company has a market capitalization of $2.76 billion, a PE ratio of 9.73, a P/E/G ratio of 1.46 and a beta of 1.30. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Lindbrook Capital LLC grew its holdings in shares of Acadia Healthcare by 1,342.0% during the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after buying an additional 671 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of Acadia Healthcare by 69.4% during the fourth quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after buying an additional 345 shares during the last quarter. Nisa Investment Advisors LLC grew its holdings in shares of Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after buying an additional 301 shares during the last quarter. Covestor Ltd grew its holdings in shares of Acadia Healthcare by 834.4% during the third quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after buying an additional 1,018 shares during the last quarter. Finally, Signaturefd LLC boosted its holdings in Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock worth $48,000 after purchasing an additional 1,004 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.